semaglutide fda news ๐Exciting that is now approved for MASH (aka fatty liver disease) โAt week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Ozempic is first GLP-1 drug
Description
The mean ( SD) changes in SD, MAGE, %CV, TAR, and TIR were also better in the semaglutide therapy group than in the dulaglutide therapy group (SD: 4.3 10.1 vs
GLP-1 agonists are a type of medication that mimics the way the natural hormone, GLP-1, works
Moreover, the analysis by Amaro et al
Your body's response to semaglutide depends on multiple factors: your baseline blood pressure, current medications, kidney function, and individual genetics
"In the enhanced comps, I'd say the vast majority of people would use some sort of pharmaceutical that aids in fat loss," he said
